Skip to main content

Neurodegenerative Krankheiten der weißen Hirnsubstanz

Pädiatrie

Part of the book series: Springer Reference Medizin ((SRM))

  • 939 Accesses

Zusammenfassung

Krankheiten der weißen Substanz des Zentralnervensystems (ZNS) werden auch als Leukoenzephalopathien (LE) bezeichnet. LE sind genetisch bedingt oder erworben. In der Diagnostik spielt die Magnetresonanztomografie (MRT) eine große Rolle.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Literatur

  • Aicardi J, Castelein P (1979) Infantile neuroaxonal dystrophy. Brain 102:727–748

    Article  CAS  PubMed  Google Scholar 

  • Amir RE et al (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185–188

    Article  CAS  PubMed  Google Scholar 

  • Anheim M, Tranchant C, Koenig M (2012) The autosomal recessive ataxias. N Engl J Med 366:636–646

    Article  CAS  PubMed  Google Scholar 

  • Baumeister FA, Auer DP, Hortnagel K et al (2005) The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome. Neuropediatrics 36(3): 221–222

    Article  CAS  PubMed  Google Scholar 

  • Bley AE, Giannikopoulos OA, Hayden D et al (2011) Natural history of infantile G(M2) gangliosidosis. Pediatrics 128:e1233–e1241

    Article  PubMed Central  PubMed  Google Scholar 

  • Cario H, Smith DE, Blom H et al (2011) Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease. Am J Hum Genet 88(2): 226–231

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cartier N, Aubourg P (2008) Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy. Curr Opin Mol Ther 10:471–478

    CAS  PubMed  Google Scholar 

  • Ceballos-Baumann A, Conrad B (Hrsg) (2005) Bewegungsstörungen 2. Aufl. Thieme, Stuttgart

    Google Scholar 

  • Chen WJ, Lin Y, Xiong ZQ et al (2011) Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 43:1252–1255

    Article  CAS  PubMed  Google Scholar 

  • De Bot ST, van de Warrenburg BPC, Kremer HPH, Willemsen MAAP (2010) Child neurology: hereditary spastic paraplegia in children. Neurology 75:e75–e79

    Article  PubMed  Google Scholar 

  • Dürr A (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 9:885–894

    Article  PubMed  Google Scholar 

  • Ehlert K, Frosch M, Fehse N et al (2007) Farber disease: clinical presentation, pathogenesis and a new approach to treatment. Pediatr Rheumatol Online J 5:15

    Article  PubMed Central  PubMed  Google Scholar 

  • Fernandez-Alvarez E, Aicardi J (2001) Movement disorders in children. Mac Keith, London

    Google Scholar 

  • Fernandez-Alvarez E, Arzimanoglou A, Tolosa E (Hrsg) (2005) Paediatric movement disorders. Libbey, New Barnet

    Google Scholar 

  • Goebel HH, Kohlschütter A, Schulte FJ (1980) Rectal biopsy findings in infantile neuroaxonal dystrophy. Neuropediatrics 11:388–392

    Article  CAS  PubMed  Google Scholar 

  • Gravel RA, Kaback MM, Proia RL et al (2008) The GM2 gangliosidoses. In: Valle D, Beaudet A, Vogelstein B et al (Hrsg) The online metabolic and molecular bases of inherited disease. McGraw-Hill, New York, S 1–91

    Google Scholar 

  • Guy J et al (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143–1147

    Article  CAS  PubMed  Google Scholar 

  • Hagberg B (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol 14:471–479

    Article  CAS  PubMed  Google Scholar 

  • Hanefeld F (1985) The clinical pattern of the Rett syndrome. Brain Dev 7:320–325

    Article  CAS  PubMed  Google Scholar 

  • Hoffmann GF, Schmitt B, Windfuhr M et al (2007) Pyridoxal 5′-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis 30(1):96–99

    Article  CAS  PubMed  Google Scholar 

  • Hornyak M, Schlüter B, Scholle S et al (2004) Das Restless-legs-Syndrom im Kindesalter. Nervenarzt 75:742–748

    Article  CAS  PubMed  Google Scholar 

  • Kohlschütter A, Eichler F (2011) Childhood leukodystrophies: a clinical perspective. Expert Rev Neurother 11:1485–1496

    Article  PubMed  Google Scholar 

  • Kono S, Miyajima H, Yoshida K et al (2009) Mutations in a thiamine-transporter Gene and Wernicke’s-like encephalopathy. N Engl J Med 360:1792

    Article  CAS  PubMed  Google Scholar 

  • Kurian M, Gissen P, Smith M et al (2011) The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol 10:721–733

    Article  CAS  PubMed  Google Scholar 

  • Licht CL, Stevnsner T, Bohr VA (2003) Cockayne syndrome group B cellular and biochemical functions. Am J Hum Genet 73:1217–1239

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mayr JA, Freisinger P, Schlachter K et al (2011) Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet 89(6): 806–812

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mengel E, Beck M, Das AM et al (2012) Morbus Niemann-Pick Typ C: Klinik, Diagnostik und Therapie. Monatsschr Kinderheilkd 160:47–54

    Article  Google Scholar 

  • Mole SE, Williams R, Goebel HH (Hrsg) (2011) The neuronal ceroid lipofuscinoses (Batten disease). Oxford University Press, Oxford

    Google Scholar 

  • Nance MA, Berry SA (1992) Cockayne syndrome: review of 140 cases. Am J Med Genet 42:68–84

    Article  CAS  PubMed  Google Scholar 

  • Nardocci N, Zorzi G, Farina L et al (1999) Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria. Neurology 52:1472–1478

    Article  CAS  PubMed  Google Scholar 

  • Neul JL et al (2010) Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68:944–950

    Article  PubMed Central  PubMed  Google Scholar 

  • Ozand PT, Gascon GG, Al Essa M et al (1998) Biotin-responsive basal ganglia disease: a novel entity. Brain 121:1267–1279

    Article  PubMed  Google Scholar 

  • Paviour DC, Revesz T, Holton JL et al (2005) Neuronal intranuclear inclusion disease: report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies. Mov Disord 20:1345–1349

    Article  PubMed  Google Scholar 

  • Petrucci S, Valente EM (2013) Genetic issues in the diagnosis of dystonia. Front Neurol 4:34. doi:10.3389/fneur.2013.00034

    Article  PubMed Central  PubMed  Google Scholar 

  • Plecko B (2012) Metabolische Epilepsien mit spezifischen Therapieoptionen. Monatsschr Kinderheilkd 160:723–733

    Article  Google Scholar 

  • Ramaswami U, Parini R, Pintos-Morell G et al (2012) Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey. Clin Genet 81:485–490

    Article  CAS  PubMed  Google Scholar 

  • Raymond GV, Eichler F, Fatemi A et al (Hrsg) (2011) Leukodystrophies. Mac Keith, London

    Google Scholar 

  • Rett A (1966) Über ein eigenartiges hirnatrophisches Syndrom bei Hyperammonämie im Kindesalter. Wien Med Wochenschr 166:723–738

    Google Scholar 

  • Robinson R, McCarthy GT, Bandmann O et al (1999) GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness. J Neurol Neurosurg Psychiatry 66:86–89

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rosewich H, Thiele H, Ohlenbusch A et al (2012) Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol 9:764–773

    Article  Google Scholar 

  • Salinas S, Proukakis C, Crosby A, Warner TT (2008) Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol 7:1127–1138

    Article  CAS  PubMed  Google Scholar 

  • Schiffmann R, van der Knaap MS (2009) Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 72:750–759

    Article  PubMed Central  PubMed  Google Scholar 

  • Schulz A, Kohlschütter A (2012) NCL – metabolische Demenzkrankheiten im Kindesalter. Monatsschr Kinderheilkd 160(8): 734–741

    Article  Google Scholar 

  • Singer H, Mink J, Gilbert D, Jankovic J (2010) Movement disorders in childhood. Saunders Elsevier, Mosby

    Google Scholar 

  • Steenweg ME, Vanderver A, Blaser S et al (2010) Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain 133:2971–2982

    Article  PubMed Central  PubMed  Google Scholar 

  • Steinfeld R, Grapp M, Kraetzner R et al (2009) Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 85(3): 354–363

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Stockler S, Plecko B, Gospe SM Jr et al (2011) Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab 104(1–2): 48–60

    Article  CAS  PubMed  Google Scholar 

  • Suzuki Y, Nanba E, Matsuda J et al (2008) β-galactosidase deficiency (β-galactosidosis): GM1 gangliosidosis and Morquio B disease. In: Valle D, Beaudet A, Vogelstein B (Hrsg) The online metabolic and molecular bases of inherited disease. McGraw-Hill, New York, S 1–101

    Google Scholar 

  • Tassin J, Durr A, Bonnet AM et al (2000) Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain 123:1112–1121

    Article  PubMed  Google Scholar 

  • van der Knaap MS, Valk J (2005) Magnetic resonance of myelination and myelin disorders, 3. Aufl. Springer, Berlin

    Book  Google Scholar 

  • Wang JL, Cao L, Li XH et al (2011) Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 134:3493–3501

    Article  PubMed  Google Scholar 

  • Weber YG, Kamm C, Suls A et al (2011) Paroxysmal choreoathetosis /spasticity (DYT9) is caused by a GLUT1 defect. Neurology 77:959–964

    Article  CAS  PubMed  Google Scholar 

  • Wémeau JL, Pigeyre M, Proust-Lemoine E et al (2008) Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. J Clin Endocrinol Metab 93:2084–2088

    Article  PubMed  Google Scholar 

  • Werner ER, Blau N, Thöny B (2011) Tetrahydrobiopterin: biochemistry and pathophysiology (review). Biochem J 438:397–414

    Article  CAS  PubMed  Google Scholar 

  • Yamada K, Miura K, Hara K et al (2010) A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations. BMC Med Genet 11:171

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zeng WQ, Al-Yamani E, Acierno JSJ et al (2005) Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am J Hum Genet 77:16–26

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zimran A (2011) How I treat Gaucher disease. Blood 118:1463–1471

    Article  CAS  PubMed  Google Scholar 

  • Zweier M et al (2010) Mutations in MEF2C from the 5q14.3q15 microdeletation syndrome region area frequent cause of severe mental retardation and dimish MECP2 and CDKL5 expression. Hum Mutat 31:722–733

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Brockmann .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Brockmann, K., Henneke, M., Kohlschütter, A. (2015). Neurodegenerative Krankheiten der weißen Hirnsubstanz. In: Hoffmann, G., Lentze, M., Spranger, J., Zepp, F. (eds) Pädiatrie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54671-6_255-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54671-6_255-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-54671-6

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Neurodegenerative Erkrankungen der weißen Hirnsubstanz
    Published:
    10 May 2019

    DOI: https://doi.org/10.1007/978-3-642-54671-6_255-2

  2. Original

    Neurodegenerative Krankheiten der weißen Hirnsubstanz
    Published:
    29 September 2015

    DOI: https://doi.org/10.1007/978-3-642-54671-6_255-1